Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Empower Clinics Inc EPWCF

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and telemedicine services; Diagnostics & Technology, comprising the diagnostic testing services provided by Kai Medical, and the sale of medical equipment by Kai Medical Canada Corp. and MediSure; and Corporate. It is focused on offering clinical trial services, such as clinical trial design, patient recruitment, data management and regulatory compliance for the pharmaceutical, biotechnology and medical device industries. It has two clinical research sites in Dallas, Texas, becoming a site management organization (SMO) with six principal investigators (PI) with multiple clinical trials under application.


GREY:EPWCF - Post by User

Post by inviolablspiriton Dec 14, 2020 12:27pm
128 Views
Post# 32100317

CBDT

CBDTThe psychedelic stocks are sure taking off today.  Certainly disappointing when CBDT doesn't take off with that sector, but I guess it's because CBDT is not a pure play in that sector.  Yet ironically, CBDT's diversity makes it by far the best play, even in that sector because it will have the facilities and expertise to actually treat patients.  These psych stocks that don't have clinics won't be able to get the full potential out of that sector like CBDT will be able to do.  The money won't be in the supply of the mushrooms, it will be in the treatment part of the patients.
<< Previous
Bullboard Posts
Next >>